ClinicalTrials.gov
ClinicalTrials.gov Menu

E-B-FAHF-2, Multi OIT and Xolair (Omalizumab) for Food Allergy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02879006
Recruitment Status : Recruiting
First Posted : August 25, 2016
Last Update Posted : January 23, 2018
Sponsor:
Information provided by (Responsible Party):
Xiu-Min Li, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2021
  Estimated Study Completion Date : December 2021